Free shipping on all orders over $ 500

NNZ-2591

Cat. No. M25421
NNZ-2591 Structure
Size Price Availability
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

NNZ-2591 is a synthetic analogue of a small peptide of cyclic glycine proline (cGP). NNZ-2591 shows orally active and cross the blood-brain barrier. NNZ-2591 shows neuroprotective after ischemic brain injury.

NNZ-2591 (30 mg/kg; p.o.) prevented scopolamine-induced memory impairment in rats. NNZ-2591 (3 mg/kg; s.c.; daily for 5 days) completely preventes brain damage and significantly reduces the L/R ratio of time taken to touch to the patch at 5 d after injury in rats.

NNZ-2591 has the potential for the research of ischemic brain injury and angelman syndrome.

Chemical Information
Molecular Weight 194.23
Formula C10H14N2O2
CAS Number 847952-38-9
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Jian Guan, et al. Recent Pat CNS Drug Discov. Insulin-like growth factor-1 and its derivatives: potential pharmaceutical application for treating neurological conditions

[2] Jian Guan, et al. Behav Brain Res. NNZ-2591, a novel diketopiperazine, prevented scopolamine-induced acute memory impairment in the adult rat

[3] Jian Guan, et al. Br J Pharmacol. IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions

[4] R V M Krishnamurthi, et al. Br J Pharmacol. A novel diketopiperazine improves functional recovery given after the onset of 6-OHDA-induced motor deficit in rats

[5] J Guan, et al. Neuropharmacology. Peripheral administration of a novel diketopiperazine, NNZ 2591, prevents brain injury and improves somatosensory-motor function following hypoxia-ischemia in adult rats

Related Peptides Products
Elcatonin

Elcatonin is a synthetic analog of eel calcitonin that increases bone density and inhibits bone resorption.

Pegmolesatide

Pegmolesatide is a synthetic peptide-based erythropoietic agent that may be used in studies related to anemia in chronic kidney disease.

Trofinetide

Trofinetide, a water-soluble analog of glycine-proline-glutamic acid (GPE), uses the unnatural amino acid 2-methylproline in place of the proline found in the natural compound, and works by enhancing synaptic activity, restoring synaptic structure, inhibiting the effects of inflammatory compounds in the brain, increasing antioxidant responses, reducing injury-induced cell death, and increasing central IGF-1 presence. It has neuroprotective activity and can be used in studies related to Rett syndrome.

Hemopressin (human, mouse)

Hemopressin is a natriuretic peptide derived from the α1 chain of hemoglobin, originally isolated from rat brain homogenates. Hemopressin is also an orally potent, selective inverse agonist at the CB1 cannabinoid receptor.Hemopressin has anti-injury sensory effects in models of inflammatory pain.

Trypsin Inhibitor (from Soybean)

Trypsin inhibitor is an alkaline polypeptide consisting of 58 amino acid residues with a pear shape throughout the molecule and a lysine activity center. It can compete with the activity center of many proteases for a lysyl group and inhibit their activities.

  Catalog
Abmole Inhibitor Catalog




Keywords: NNZ-2591 supplier, Peptides, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.